NIC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now at $148.5: the setup looks extended (RSI71) and near resistance (R1~151.8) with momentum starting to cool (MACD histogram contracting).", "Near-term pattern-based outlook is unfavorable (model suggests mild 1-day upside but meaningful risk over 1-week/-1-month), which is not ideal for an impatient entry.", "Fundamentals and Wall Street stance are broadly positive (Q4 growth + multiple target raises), so this is more of a \u201cbuy on a pullback\u201d than a \u201cchase today.\u201d"]
["Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating an established uptrend.", "Momentum: MACD histogram is positive (0.857) but contracting, suggesting upside momentum is fading rather than accelerating.", "RSI: RSI_6 at 71.19 indicates the stock is stretched/overbought short-term, increasing odds of a pause or pullback.", "Levels: Pivot support ~146.57 (near current price); stronger supports at ~141.38 (S1) and ~138.17 (S2). Resistance at ~151.76 (R1) then ~154.96 (R2).", "Pattern/odds: Similar-pattern analysis implies ~+2.02% next day probability, but -7.7% next week and -12.07% next month skew\u2014bearish near-term risk profile despite the longer uptrend."]
with double-digit YoY revenue growth and faster EPS growth.", "Analyst targets were raised across multiple firms in late Jan 2026, reinforcing constructive Street expectations.", "Options market positioning/flow is decisively call-skewed, consistent with bullish sentiment."]
plus waning momentum (contracting positive MACD histogram) increases pullback risk.", "Pattern-based forward skew points to higher odds of weakness over the next week to month.", "No fresh news catalysts in the past week to justify paying up near resistance levels."]
["Latest quarter: 2025/Q4.", "Revenue: $96.34M, +12.92% YoY (solid top-line growth).", "Net income: $40.32M, +16.95% YoY (profit growth outpacing revenue).", "EPS: $2.65, +20.45% YoY (strong per-share growth trend)."]
["Recent trend: Multiple price target increases in Jan 2026 (Hovde to $190; Maxim to $173; KBW to $170; Piper to $148; KBW also raised in Dec 2025 to $165).", "Ratings mix: Predominantly bullish (Outperform/Buy) with one Neutral (Piper).", "Wall Street pros: Strong Q4 execution, stable NIM commentary, credit quality positives, and earnings beat-driven confidence.", "Wall Street cons: Neutral view highlights less sequential loan growth; current price (~$148.5) already sits around the most cautious target ($148), limiting immediate upside vs nearer-term technical risk."]
